Diabetic Lancets Market By Type (Reusable Lancets and Disposable Lancets), By Application (Hospital, Clinic, and Other), Industry Trends, Estimation & Forecast, 2023-2030

Market Overview

Diabetic lancets are the small, sharp objects that are used to prick the skin for blood glucose monitoring. Diabetic lancets are two type of lancets disposable lancets and reusable lancet. Disposable lancets are for single-use, and reusable lancets are used again by individuals. Lancets vary in size and are smaller and therefore appropriate for children. The same lancets may not draw a proper amount of blood for adults, so the lancing devices are designed to grip the lancet firmly and are operated by simply clicking a button.

Diabetic Lancets market was valued at 1152.6 million US$ in 2022 and is projected to reach 3174.2 million US$ by 2030, at a CAGR of 13.5% during the forecast period.

Market Dynamics

Increasing prevalence of diabetes has raised the demand for diabetic lancets. According to a report published by the Centers for Disease Control and Prevention (CDC), as of 2015, 30.3 million Americans, 9.4% of the U.S. population, have diabetes. According to the CDC, approximately 7% of France’s adult population, which is 45 million have diabetes. According to international diabetes federation, in 2017, there were over 7,476,800 cases of diabetes in Germany. Prevalence of diabetes in adults has increased to 12.2%. According to the National Institute for Health and care excellence around 400,000 adults in the UK are affected by type 1 diabetes, and around 27,000 children and young people have either type 1 or type 2 diabetes. According to the World Health Organization (WHO), in 2016, almost 10% of adults in China which is about 110 million people have diabetes. The prevalence of diabetes in China is 10.9%. According to the Indian Council for Medical Research, in 2017, India represented 49% of the world’s diabetes burden, with an estimated 72 million cases, and it is expected to increase by 134 million in 2025. Diabetes prevalence has increased by 64% across India. According to international diabetes federation, in 2017, there were over 1,826,100 cases of diabetes in South Africa. Prevalence of diabetes in adults has increased to 5.4%. According to the International Diabetes Federation Atlas, 19.3% of adults aged 20 to 79 in the United Arab Emirates have diabetes. In Bahrain, the prevalence of diabetes rises to 19.6% and 20% for Kuwait, Qatar, and Saudi Arabia. Further, Rise in home diagnostic blood tests are key driving factors of the market. However, Low product adoption in developing countries might hamper market growth. The final pricing structure of diabetic lancets with additional shipping costs is substantially high for emerging economies struggling to establish effective regional healthcare facilities. The lack of proper healthcare facilities in the developing countries restricts the broad adoption of diabetic lancets in such markets, thereby acting as market barriers to global growth. Moreover, growth in federal blood donation camps and non-profit medical camps would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global Diabetic Lancets market is mainly classified based on Type, Application. Type is further segmented into Reusable Lancets, Disposable Lancets. By Application, the market is divided into Hospital, Clinic, Other.

Disposable diabetic lancet was dominating the global diabetic lancets market by type in 2019. The recommendation and policy to use disposable lancets by the regulatory bodies are boosting the global diabetic lancets market. The Centers for Disease Control and Prevention (CDC) recommends using Disposable diabetic lancets, as reusable lancets increase the risk of HBV infection and other blood-borne illnesses. According to the CDC, there have been several outbreaks of hepatitis B virus (HBV) have been linked to improper blood glucose monitoring, with 15 outbreaks among individuals and healthcare providers. According to Section 1389-dd (4) of the New York State (NYS) Public Health Law indicates that lancets after one use should be delivered for disposal to a general hospital and residential health care. Research has documented that lancets remain infectious for prolonged periods. Safe disposal programs reduce reuse of lancets, reduce circulation time of lancets, reduce the percentage of contaminated lancets in circulation, reduce risk of exposure and these programs need to be encouraged and supported.

Regional Analysis
Based on geography, the global Diabetic Lancets market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Asia Pacific was dominating the global diabetic lancets market in 2019. The wide application of diabetic lancets during blood monitoring tests is one of the major factors impacting the gain in market traction of end-products in Asia Pacific. According to the International Diabetes Federation, the number of diabetes in China is estimated to be 1 in 10 out of Chinese adult. China has the highest number of diabetic cases worldwide, with around 116 million people suffering from the disease. According to the National Diabetes and Diabetic Retinopathy Survey, the prevalence of diabetes in India was 11.8% in 2019. In 2019, there are 72.96 million cases of diabetes in the adult population of India. The International Diabetes Federation has estimated that the number of diabetic patients in India will increase to 123 million by 2040. According to Diabetes Singapore, in 2019, 440,000 people have Diabetes in Singapore.

Competitive landscape

Key players operating in the Diabetic Lancets industry include Roche, Medisana, Becton Dickinson, Natus Medical, Owen Mumford, Ascensia Diabetes Care, Intrinsyk Medical Devices, LifeScan, Cardinal Health, Simple Diagnostics, Biotest Medical, CML Biotech, BioCare Corporation, Arkray.

Commercialization of approved products and formation of strategic collaborations are among the most followed business strategies of the top companies, with a focus on maintaining competitive advantage over others. The companies are thus focused on product approvals and expansion of business activities on a global scale. As of 2019, LifeScan has the highest revenue for diabetic lancets, followed by Roche.

Diabetic Lancets Market Key Segments

By Type
• Reusable Lancets
• Disposable Lancets

By Application
• Hospital
• Clinic
• Other

Key Global Diabetic Lancets Industry Players
• Roche
• Medisana
• Becton Dickinson
• Natus Medical
• Owen Mumford
• Ascensia Diabetes Care
• Intrinsyk Medical Devices
• LifeScan
• Cardinal Health
• Simple Diagnostics
• Biotest Medical
• CML Biotech
• BioCare Corporation
• Arkray

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Diabetic Lancets Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Increasing prevalence of diabetes
3.3.2. The rise in home diagnostic blood tests
3.4. Restraints
3.4.1. Low product adoption in developing countries
3.5. Opportunity
3.5.1. Growth in federal blood donation camps and non-profit medical camps
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis

4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Reusable Lancets
4.2.1. Market Size & Forecast
4.3. Disposable Lancets
4.3.1. Market Size & Forecast

5. Application Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Hospital
5.2.1. Market Size & Forecast
5.3. Clinic
5.3.1. Market Size & Forecast
5.4. Other
5.4.1. Market Size & Forecast

6. Diabetic Lancets Market Regional Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. North America Diabetic Lancets Market
6.2.1. North America Market Size & Forecast, By Country
6.2.2. North America Market Size & Forecast, By Type
6.2.3. North America Market Size & Forecast, By Application
6.2.4. The U.S.
6.2.4.1. Market Size and Forecast
6.2.5. Canada
6.2.5.1. Market Size and Forecast
6.2.6. Mexico
6.2.6.1. Market Size and Forecast
6.3. Europe Diabetic Lancets Market
6.3.1. Europe Market Size & Forecast, By Country
6.3.2. Europe Market Size & Forecast, By Type
6.3.3. Europe Market Size & Forecast, By Application
6.3.4. Germany
6.3.4.1. Market Size and Forecast
6.3.5. France
6.3.5.1. Market Size and Forecast
6.3.6. UK
6.3.6.1. Market Size and Forecast
6.3.7. Italy
6.3.7.1. Market Size and Forecast
6.3.8. Spain
6.3.8.1. Market Size and Forecast
6.3.9. Rest of Europe
6.3.9.1. Market Size and Forecast
6.4. Asia-Pacific Diabetic Lancets Market
6.4.1. Asia-Pacific Market Size & Forecast, By Country
6.4.2. Asia-Pacific Market Size & Forecast, By Type
6.4.3. Asia-Pacific Market Size & Forecast, By Application
6.4.4. Japan
6.4.4.1. Market Size and Forecast
6.4.5. China
6.4.5.1. Market Size and Forecast
6.4.6. Australia
6.4.6.1. Market Size and Forecast
6.4.7. India
6.4.7.1. Market Size and Forecast
6.4.8. South Korea
6.4.8.1. Market Size and Forecast
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market Size and Forecast
6.5. South America Diabetic Lancets Market
6.5.1. South America Market Size & Forecast, By Country
6.5.2. South America Market Size & Forecast, By Type
6.5.3. South America Market Size & Forecast, By Application
6.5.4. Brazil
6.5.4.1. Market Size and Forecast
6.5.5. Argentina
6.5.5.1. Market Size and Forecast
6.5.6. Rest of South America
6.5.6.1. Market Size and Forecast
6.6. Middle East & Africa Diabetic Lancets Market
6.6.1. Middle East & Africa Market Size & Forecast, By Country
6.6.2. Middle East & Africa Market Size & Forecast, By Type
6.6.3. Middle East & Africa Market Size & Forecast, By Application
6.6.4. GCC Countries
6.6.4.1. Market Size and Forecast
6.6.5. Egypt
6.6.5.1. Market Size and Forecast
6.6.6. South Africa
6.6.6.1. Market Size and Forecast
6.6.7. Rest of Middle East & Africa
6.6.7.1. Market Size and Forecast

7. Company Profile
7.1. Roche
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2. Roche Product Category, Application, and Specification
7.1.3. Roche Financial Performance (2016-2018)
7.1.4. Main Business/Business Overview
7.2. Medisana
7.3. Becton Dickinson
7.4. Natus Medical
7.5. Owen Mumford
7.6. Ascensia Diabetes Care
7.7. Intrinsyk Medical Devices
7.8. LifeScan
7.9. Cardinal Health
7.10. Simple Diagnostics
7.11. Biotest Medical
7.12. CML Biotech
7.13. BioCare Corporation
7.14. Arkray